Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (1y) (2010 - 2026)
Ionis Pharmaceuticals (IONS) EBITDA Margin Growth (1y) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBITDA Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
3,609.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,536.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Ionis Pharmaceuticals |
12.23 Bn |
10.31 Bn |
243.11 Mn |
6,387.00 |
| Date | Value |
| Mar 31, 2026 |
6,387.00 |
| Dec 31, 2025 |
-5,656.00 |
| Sep 30, 2025 |
888.00 |
| Jun 30, 2025 |
702,014.00 |
| Mar 31, 2025 |
1,353.00 |
| Dec 31, 2024 |
-4,702.00 |
| Sep 30, 2024 |
-1,174.00 |
| Jun 30, 2024 |
1,853.00 |
| Mar 31, 2024 |
-3,766.00 |
| Dec 31, 2023 |
13,507.00 |
| Sep 30, 2023 |
-6,232.00 |
| Jun 30, 2023 |
1,604.00 |
| Mar 31, 2023 |
-4,693.00 |
| Dec 31, 2022 |
-18,709.00 |
| Sep 30, 2022 |
2,748.00 |
| Jun 30, 2022 |
-589.00 |
| Mar 31, 2022 |
4,189.00 |
| Dec 31, 2021 |
10,515.00 |
| Sep 30, 2021 |
-4,168.00 |
| Jun 30, 2021 |
34,008.00 |